Taste Properties of HIV Inhibitor

ViiV Healthcare

Status and phase: Completed; Phase 1

Conditions: HIV Infections

Treatments: Drug: BMS-955176

Study type: Interventional

Funder types: Industry

Identifiers

NCT02608918

AI468-065 (Other Identifier)

206301

Details and patient eligibility

About

The purpose of the study is to assess the taste properties of HIV inhibitor

Enrollment: 8 patients

Sex: All

Ages: 25 to 80 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com

Inclusion Criteria:

• Men and women of non-childbearing potential professional sensory panelists
• Aged between 25 and 80 years

Exclusion Criteria:

• History of relevant drug or food allergies, cardiovascular or Central nervous system (CNS) disease, clinically significant pathology, history of mental illness
• Positive HIV test

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

8 participants in 1 patient group

BMS-955176

Experimental group

Description:

BMS-955176 specified dose on specified days

Treatment:

Drug: BMS-955176